CP-154,526
Chemical compound From Wikipedia, the free encyclopedia
CP-154,526 is a potent and selective antagonist of the corticotropin releasing hormone receptor 1 developed by Pfizer.[1]
![]() | |
Names | |
---|---|
Preferred IUPAC name
N-Butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[3,2-e]pyrimidin-4-amine | |
Identifiers | |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C23H32N4 | |
Molar mass | 364.52698 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
CP-154,526 is under investigation for the potential treatment of alcoholism.[2][3]
See also
References
Further reading
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.